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https://www.nature.com/articles/hr201792 In this study, the authors used vascular smooth-muscle cell-specific ATPB1 knockout mice that exhibited hypertension with increased intracellular calcium concentration. ATPB1 encodes membrane calcium ATPase. In this animal model, the expression of L-type calcium channel was upregulated and mice were sensitive to the hypotensive effect of dihydropyridine calcium-channel blocker as compared with other classes of antihypertensive drugs. 
